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Summary
Binding of basic fibroblast growth factor (FGF2) to its high
affinity receptors requires the presence of specific heparan
sulfate (HS) moieties on the cell surface that act as coreceptors. To determine the contribution of cell-surface HS
to modulation of FGF2-dependent cell growth, we studied
the changes in the cell mass and FGF2 binding of
endothelial cell HS under normoxic and hypoxic conditions
in vitro. Both large vein and cardiac microvascular
endothelial cells cultured under hypoxic conditions
demonstrated an increase in the ratio of cell-surface HS to
chondroitin sulfate (CS), as well as an increase in the
number of low affinity (HS-associated) binding sites for
FGF2 with no change in the apparent Kd. This increase in
the number of HS-FGF2 binding sites, in the absence of a
significant change in FGF receptor expression, resulted in
enhanced responsiveness of hypoxic, compared with
normoxic, endothelial cells to FGF2 stimulation.
Gene expression studies demonstrated increased

Introduction
Hypoxia is known to alter many endothelial cell properties by
increasing cellular levels of hypoxia-inducible factor (HIF)-1α,
which in turn amplifies expression of angiogenesis-related
genes such as vascular endothelial growth factor (VEGF) and
its receptor flt-1 (Carmeliet et al., 1998; Iyer et al., 1998),
angiopoietin-1 (Mandriota and Pepper, 1998) and endothelial
nitric oxide synthase (Arnet et al., 1996) among others. In
addition, hypoxia has a profound effect on the cell-surfaceassociated matrix, and its efffects include altering the
expression of heparan-sulfate-carrying core proteins
(Humphries et al., 1986; Karlinsky et al., 1992) and integrins
(Rusnati et al., 1997). These changes in cell-surface-associated
matrix and, particularly, its heparan sulfate content, can have
profound effects on the ability of heparin-binding growth
factors such as FGF2 to stimulate endothelial cell growth and
migration.
Heparan sulfate proteoglycans can mediate both the heparinbinding growth-factor–receptor interaction at the cell surface
and accumulation and storage of these growth factors in the

expression of the key regulatory enzyme responsible for HS
chain synthesis, 1,4 GlcNAc transferase (GlcNAcT-I), as well
as increased expression of 2-O sulfotransferase (HS2ST), the
enzyme responsible for sulfation of IdoA, a crucial part of
the HS-FGF2 binding site. Transduction of cells with an
adenovirus encoding a HIF-1α expression construct resulted
in a similar increase in GlcNAcT-I and HS2ST expression.
We conclude that hypoxia increases endothelial cell
responsiveness to FGF2 by promoting preferential synthesis
of HS rather than CS chains and increasing the number of
FGF2-binding sites on HS chains. Both of these events are
mediated by a HIF-1α-dependent increase in expression of
the enzymes GlnNAcT-I and HS2ST. This shift in cellsurface HS composition results in enhanced cell sensitivity
to FGF2-induced growth stimulation.
Key words: FGF2, Signaling, Hypoxia, Angiogenesis, Heparan
sulfate, Endothelial cells

extracellular matrix (Rosenberg et al., 1997; Tumova et al.,
2000). The presence of HS is required for FGF2-dependent
activation of cell growth in vitro (Rapraeger et al., 1991; Yayon
et al., 1991), and removal of HS chains from the cell surface
by enzymatic digestion greatly impairs FGF2 activity and
inhibits neovascularization in vivo (Sasisekharan et al., 1994).
In the case of FGF2, a specific heparan-binding domain
including Asp28, Arg121, Lys126 and Gln135 has been identified
(Faham et al., 1996; Ornitz et al., 1995) that interacts with a
specific oligosaccharide sequence in HS (Schlessinger et al.,
2000; Stauber et al., 2000). In addition, HS also interact with
FGF receptor-1 (Kan et al., 1993; Schlessinger et al., 2000).
FGF2 binding to the cell surface HS leads to dimerization of
bFGF, which facilitates growth-factor binding to FGFR1,
which is, in turn, followed by receptor dimerization and
activation of intracellular signaling cascades. The interactions
between HS and both FGF2 and FGF receptor are primarily in
the form of hydrogen bonds between sulfate groups in 2-O
(FGF2) and 6-O (FGF receptor) positions (Schlessinger et al.,
2000; Stauber et al., 2000). Therefore any alteration in HS
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chain composition, the extent of its sulfation or the position of
sulfate groups on the cell surface by means of altered synthesis,
degradation or modification of glycosaminoglycan (GAG)
chains can, conceivably, affect growth-factor signaling. The
importance of HS in growth-factor-dependent signaling is
emphasized by findings in Drosophila, where several major
signaling pathways including FGF, Wnt, Hedgehog and TGFβ, have been shown to depend on the presence of sulfated HS
chains in glypican and syndecan (Baeg and Perrimon, 2000;
Lin et al., 1999; Tsuda et al., 1999).
Glycosaminoglycan chain biosynthesis involves a number of
enzymes. An enzyme 1,4-N-acetylhexosaminyl transferase
(GlcNAcT-I) initiates the HS biosynthetic pathway by
transferring glucuronic acid (GlcA) and N-acetylglucosamine
(GlcNAc) to the core protein tetrasaccharide linkage region
(Fritz et al., 1994; Kitagawa et al., 1999). The elongating HS
chain can then be modified by several enzymes, including
GlcNAc N-deacetylase/N-sulfatransferase (NDST1 and 2),
which mediates N-sulfation, C5-epimerase, an enzyme
mediating conversion of glucuronic to iduronic acid
(Rosenberg et al., 1997) and 2-O and 6-O sulfotransferases
(HS2ST and HS6ST, respectively), which are involved in the
generation of the FGF2-binding site (HS2ST) and FGF2
signaling (HS6ST) (Bai and Esko, 1996; Pye et al., 1998).
We designed the present study to analyze the effect of
hypoxia on the composition of heparan sulfates on the surface
of two different populations of primary endothelial cells large-vein-derived human endothelial cells (HUVEC) and
primary rat cardiac microvascular endothelial cells (CMEC).
In addition, we also examined the expression of key enzymes
involved in HS synthesis in hypoxic as well as HIF-1αencoding adenovirus-transducted endothelial cells. We found
that hypoxia leads to a significant shift from CS to HS chain
synthesis owing to increased expression of HS synthesis
enzyme GlcNAcT-I, as well as an increase in the number of
HS-FGF2 binding sites owing to increased expression of 2-O
sulfotransferase HS2ST. The increase in expression of both of
these enzymes is mediated by HIF-1α. These changes in the
HS cell-surface composition resulted in a significant increase
in FGF2-induced cell proliferation.
Materials and Methods
Endothelial cell cultures
Cardiac microvascular endothelial cells (CMEC) were harvested from
neonatal rats by enzymatic dissociation as previously described
(Edelberg et al., 1998). The cells were cultured in Dulbecco’s
modified Eagle’s medium (Gibco BRL, Grand Island, NY)
supplemented with 20% fetal bovine serum (HyClone, Logan, UT),
penicillin (100 units/ml) and streptomycin (100 mg/ml). All
experiments were performed on cells three to four passages from the
primary culture. Human umbilical vascular endothelial cells
(HUVEC) were purchased from Clonetics (San Diego, CA). Cells
were cultured in M199 medium (Gibco BRL, Grand Island, NY)
supplemented with 20% fetal bovine serum, 10 units/ml heparin
(Elkins-Sinn, Inc. MA), 30 µg/ml endothelial mitogen (Biomedical
technologies Inc., MA) and streptomycin/penicillin mixture. Cells in
the third to fifth passage were used for the experiments. Exogenous
HS for cell growth studies was obtained from Sigma and the amount
calculated to double the total HS mass was used.
For hypoxia studies, cell cultures were incubated in a sealed plastic
chamber containing 5% CO2/95% nitrogen mixture in a 37°C
incubator. The oxygen level in the chamber was monitored using an

oxygen analyzer (Vascular Technology, Inc., MA), and it remained at
1-3% O2 for up to 72 hours of the incubation. Control cultures were
maintained in a 95% air/5% CO2 tissue culture incubator.
Transduction of HUVEC with a HIF-1α-encoding adenovirus
A recombinant adenovirus construct expressing the HIF1α-VP16
hybrid (Vincent et al., 2000) was a kind gift from K. Vincent
(Genzyme Corp, Cambridge, MA). Briefly, the full length HIF-1α
gene was isolated from a HeLa cell cDNA library and cloned into the
expression vector, pcDNA3 (Invitrogen, Carlsbad, CA). The HIF1αVP16 hybrid was constructed by truncating HIF1α and then joining
the transactivation domain of HSV VP16 downstream of HIF-1α. The
media in which cells were transfected contained adenovirus-encoding
HIF1α. For HUVEC and CMEC transfection, the cells were incubated
in 5 ml of adenovirus-containing media containing ~2×1010 IU/ml
virus with a particle/infectious unit ratio of ~50 at 37°C. Five hours
later, an equal amount of fresh medium was added, and the cells were
incubated continually overnight. Successful transduction was
confirmed by showing increased expression of HIF-1α-VP16 and
VEGF in transducted cell but not in control cells by western blotting.
Transduction of HUVEC and CMEC with the Ad2 vector was used
as a control.
Metabolic labeling of proteoglycans
Determination of the total mass of cell-surface-associated
glycosaminoglycans was carried out as previously described
(Shworak et al., 1994). Briefly, the endothelial cell cultures were
incubated for 24 hours with sulfate-free DMEM supplemented with
1% Neutrodoma-SP (Boehringer Mannheim, Indianapolis, IN) in
hypoxic and normoxic condition then trypsinized with Trypsin/EDTA
(Gibco BRL, Grand Island, NY) followed by centrifugation at 15,000
g for 10 minutes at 4°C. Total proteoglycans (PG) were isolated from
the supernatant by DEAE chromatography. GAGs were cleaved from
the total PG pool by β-elimination. After phenol extraction and
ethanol precipitation of GAGs, the relative contents of HS and CS
were determined by appropriating enzyme digests with chondroitinase
ABC or Flavobacterium heparatinase 1 and 3 (Sigma). Digested HS
or CS was collected by ethanol precipitation and dissolved in water
containing 0.0005% triton X-100. Quantification of HS and CS was
done spectrophotometrically using Alcian blue solution containing 4
M guanidine HCL, 27 mM H2SO4, 0.25% Triton X-100 and 0.25%
alcian blue (Fluka, Ronkonkoma, NY) at A600 wavelength. A
concentration scale of dilutions of heparan sulfate (Fluka,
Ronkonkoma, NY) was used as a standard. Using this approach, the
sum of HS and CS accounted for >98% of the total PG sulfate.
Scatchard analysis of FGF2-binding sites
For determination of the number and affinity of FGF2-HS binding
sites, endothelial cells were grown to near confluence in 24-well
dishes (Gibco BRL, Grand Island, NY) in 10% FBS-DMEM. After
two washes with cold PBS, 200 µl of binding buffer (25 mM HEPES,
pH 7.4, 0.1% BSA, 0.05% gelatin in M199 medium), 4000 CPM (0.5
ng/ml) 125I-FGF2 (New England Nuclear, Boston, MA specific
activity 2000 C/mmol) and increasing amounts (0-500 ng/ml) cold
rFGF2 (Chiron Corp, Sunnyvale, CA) were added to each well, and
the cells were incubated at 4°C for 2 hours with gentle agitation.
Binding in the presence of 500 ng/ml rFGF2 (1000-fold excess) was
considered nonspecific. To determine total 125I-FGF2 binding, the
cells were washed three times with 1 ml PBS containing 0.1% BSA
and then incubated for 5 minutes with 1 ml 1 M NaOH at room
temperature with vigorous shaking. Following this, 0.4 ml aliquots
were counted in a 1272 CliniGamma counter (LKB). Low affinity
binding of FGF2 was determined specifically by salt extraction (5
minutes in 1 ml cold 2 M NaCl) before treatment with NaOH as
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Table 1. Specific gene primers used for PCR analysis
Gene
GlcNAcT-I
HS2ST
CS/DS2ST
HS6ST1
HS6ST2
NDST1
NDST2
Epimerase

Accession No.
AF000416
AB024568
AB020316
NM_004807
AB024565
NM_001543
NM_003635
AF003927

Sense
CTAAGCTGCAGGGAAATAAA
AGGATTTTATCATGGACACG
GCACCCAATATGAAACATCT
CTACATGAGCCACATCATTG
CAAAGTCCTTCTGGAAAGTG
ATCTTCTGCCTGTTCAGCGT
CATGAAGGTGGCTGATGTTG
AGGTGGTTAGGTTGATTGCG

described (Bono et al., 1997). Cell counts determined by Coulter
Counter were employed to establish the number of cells per well.
Background counts were subtracted from all samples. Scatchard
analysis of the specifically bound material versus the molar amount
of cold competitor was carried out using GraphPad Prism 3.0
software. All experiments were done in triplicate and repeated at least
twice.
RNA isolation and northern analysis
For the RNA analysis of the time course of expression of syndecans,
glypican, perlecan and FGF receptor 1, total RNA was made from
cultured cells using the Tri-Reagent solution (Sigma, MO). The 10 µg
RNA pellet was dissolved in RNase-free water, fractionated on a 1.3%
formaldehyde-agarose gel and transferred to GeneScreen Plus (Du
Pont) filter. The cDNA probes of interest were labeled with α32PdCTP (New England Nuclear) with a random-priming labeling kit
(Boehringer, Indianapolis, IN) and purified from unincorporated
nucleotides using G-50 Quick Spin Columns (Boehringer,
Indianapolis, IN). The typical specific activity of the probes used in
the experiments was 1-2×109 cpm/µg. The blots were hybridized at
68°C for 3 hours in QuikHyb solutions (Stratagene, La Jolla, CA).
After the hybridization, blots were washed twice in 2×SSC, 0.1% SDS
for 15 minutes at room temperature and then twice in 0.1×SSC, 0.1%
SDS for 15 minutes at 60°C. Autoradiography was carried out with
Kodak XAR film at –80°C for 16-20 hours.
Cell growth assay
CMEC or HUVEC were plated at 10-12,000 cells per well in 24-well
plates and cultured either in the hypoxic chamber (average O2 content
2% over 72 hours) or in the normal oxygen environment for 16 hours
in 0.25% FBS-DMEM (growth arrest medium) prior to initiation of
FGF2 stimulation. At that time, 10 ng/ml FGF2 (Chiron Corp) was
added, and the cell counts were determined at 24, 48 and 72 hours,
respectively, in a Coulter Counter (Coulter Corp. Cortland, NY). Cell
growth data are shown as a percentage increase from the baseline. All
experiments were carried out in triplicate.
RT-PCR analysis of HS biosynthetic enzyme expression
The reverse transcription reaction was performed on 2 µg of total
RNA from normoxic, hypoxic and HIF1α-transfected cells with oligo

Antisense

Location

Size

TTGCTGTCTGTTGTTTGAAG
TCTTTCCTGTGCGATAGAGT
CCTTAGGACAGTGAGACTGC
GAGTTAAGAGCGAGTGCTGT
TGTCTCTACGCTCCCTATGT
CTCATTGGCCTTGAAGAAGC
CGGATTAAGCAGCACTGTCA
GCAGTTGATTGATGTGGGTG

127-692
762-1204
2305-2775
1314-1753
925-1513
496-965
1011-1610
689-1332

546
443
451
440
589
450
580
624

dT primer (Gibco BRL custom primer) at 37°C for 90 minutes.
Specific gene primers of each interested enzyme for PCR analysis
were designed by using Biology WorkBench 3.2 software on the basis
of the published sequences (Table 1).
Primers for 18S RNA, which produce a 300 bp fragment (Amicon
Inc. Beverly MA), were used with amplification of each sample to
control for RNA loading. The PCR conditions were as follows: 94°C
denaturing for 1 minute, 58°C annealing and 72°C extending for a
total of 32 cycles. The PCR products were subjected to electrophoresis
on a 1% agarose gel, visualized by ultraviolet activation of
incorporated ethidium bromide and photographed. The photos were
scanned and quantified using Image-Quant software (Molecular
Dynamic). Statistical analysis used the ratio of the PRC product for
the enzymes we were studying and that of18S. All experiments were
repeated three times.
The quantitation of gene expression was confirmed by Real Time
PCR technique using the GeneAmp 5700 system with SYBR Green
PCR core reagents (PE Applied Biosystems, Foste City,CA). The
primers were designed and selected as optimal primer pairs using
Primer ExpressTM software (PE Applied Biosystems) as shown in
Table 2, and PCR reactions were run under PE Applied Biosystems
universal thermal cycling conditions.
Quantitative analysis of gene expression was carried out using the
GeneAmp 5700 system software. To eliminate the effect of variation
in the amount of total RNA among the various samples, 18S RNA
was amplified for each RNA sample in a specific PCR reaction.
The ratio of the specific RNA transcript was then adjusted for the
amount of 18S RNA to allow quantitative comparisons among the
samples.

Results
Hypoxia alters glycosaminoglycan expression on
endothelial cells
To explore the effect of hypoxia on HS chain composition in
cultured endothelial cells, the cell-surface-associated GAG
content and the HS mass were measured by steady-state
incorporation of radioactively labeled sulfate into CMEC and
HUVEC. After 48 hours of hypoxia, there was a slight decline
in the total GAG content in both cell types (HUVEC, 65.8±2.4
versus 53.8±5.2; CMEC, 56.4±0.3 versus 47.1±0.1 CPM/µg
protein normoxia versus hypoxia) (Fig. 1A). At the same time,

Table 2. Optimal primer pairs for Real Time PCR
Gene
GlcNAcT-I
HS2ST
CS/DS2ST
HS6ST1
HS6ST2
NDST1
NDST2
Epimerase

Accession No.
AF000416
AB024568
AB020316
NM_004807
AB024565
NM_001543
NM_003635
AF003927

Sense
CCTTGTGGCCCTGCCA
ATTATGATGCCGCCCAAGTT
GTCAGCAAGCCCCCCT
GCGTGGAGGTGGATGAAGAC
CCTGGTGCGCAACATCC
TCCTGGAGTCCAGCCGC
AGACCGGTACTGCGTGGAGT
CCATCTATGACCTCCGGCAC

Antisense
GTTACATCAAAACCATGCTGGACT
AAGAGCATCGCCACCGC
TCGATTGGCTCCTCGGTTT
TGCATGTCCAGGTCGTTGAG
TGCATTTCTTCTGCCCCAC
CGTGGGCATGTCACCCTT
GGCTGTGCTGCTGGGCT
AGTCCCAGCGGGCCAG

Location

Size

1782-1844
370-431
1205-1272
1085-1145
298-359
731-795
498-562
1226-1285

62
61
67
60
61
64
64
59
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Table 3. Characterization of high and low affinity FGF2 binding sites on endothelial cells under normoxic and hypoxic
conditions
High affinity Kd
(×10–11 M)

FGF R sites per cell
(×103)

Low affinity Kd
(×10–9M)

FGF2-HS sites/cell
(×105)

CMEC

Normoxia
Hypoxia

3.9±1.1
3.3±1.4

2.5±0.6
2.7±1.3

2.5±0.8
2.5±1.3

1.3±0.2
2.7±0.2

HUVEC

Normoxia
Hypoxia

2.1±0.8
2.5±0.9

2.1±0.7
3.0±0.3

1.9±0.5
2.0±0.4

1.6±0.8
2.5±0.7

CMEC, cardiac microvascular endothelial cells; FGF R high affinity binding site (FGF receptor); HUVEC, human umbilical vein endothelial cells, HS,
Heparan sulfate.

there was a significant increase in the HS fraction of the total
GAG content (37.5±1.4% versus 51.9±0.4% in CMEC and
19.7±3.2% versus 39.4±4.3% in HUVEC; P<0.05, normoxia
versus hypoxia for both) signifying preferential synthesis of
HS rather than CS chains on core proteins. The extent of the
increase in the cell-surface-associated HS mass was more
prominent in HUVEC compared with CMEC (Fig. 1B).
However, in both cell types hypoxia was associated with a
significant increase in the HS/CS ratio (1.8 fold for CMEC and
2.6 fold for HUVEC, Fig. 1C).
To test whether these changes in the GAG content on the
endothelial cell surface altered binding properties of HSbinding proteins, we have measured the number of low affinity
binding sites for FGF2, a prototypical HS-binding growth
factor. In both HUVEC and CMEC cells, there was nearly a
doubling in the number of low affinity binding sites for FGF2,
whereas the apparent Kd of this interaction remained the same
(Table 3). At the same time, there was no change in either the
Kd or the number of high affinity (FGF receptor) binding sites
(Table 3). Thus in the case of both HUVEC and CMEC,
hypoxia induced a significant increase in the number of HSFGF2 binding sites per cell (Fig. 1D).
B
1.0

2.5

Heparan sulfate

A

GAG

0.8
0.6
0.4
0.2
0.0

2.0

1.0
0.5
0.0
HUVEC CMEC

D

*

2.5
2.0

2.5
2.0

*

1.5
1.0
0.5

FGF2-HS

HS/CS Ratio

3.0

*

1.5

HUVEC CMEC

C

Effect of hypoxia on expression of HS-carrying core
proteins and FGF receptor
The change in the cell surface GAG population and the HS cell
mass under hypoxia can result from altered expression of HScarrying core proteins (syndecans or glypican), from changes
in glycanation of mature cores (i.e., a shift from HS to CS chain
attachment), increased frequency of FGF2 binding sites per HS
chain or a combination of all three. To explore these
possibilities, we carried out northern blot analysis of syndecan1, 2 and 4 and glypican-1 core gene expression under normal
cell culture conditions and following 24 hours of hypoxia. In
both endothelial cell types, hypoxia induced a reduction in
syndecan-1, 2 and 4 and glypican-1 expression (and this was
more pronounced in HUVEC) (Fig. 2). At the same time, there
was no change in expression of extracellular matrix
proteoglycan perlecan. Thus a change in expression of HScarrying proteins could not have contributed to increased HS
cell mass and the increased number of FGF2 low affinity (HS)
binding sites.
To confirm the results of the Scatchard analysis, which
suggested no significant change in the number of FGFreceptor-binding sites on the cell surface after 24 hours of

*

*

1.5
1.0
0.5
0.0

0.0
HUVEC CMEC

HUVEC CMEC

Fig. 1. Hypoxia-induced changes in endothelial cell HS matrix.
Changes in the cell-surface-associated GAG content (A), heparan
sulfate (B), HS/CS ratio (C) and FGF2-HS binding sites (D) are
shown as a ratio between hypoxic and normoxic states for cardiac
microvascular endothelial cells (striped bars) and human umbilical
vein endothelial cells (gray bars). * denotes a significant change in
the index under hypoxic versus normoxic conditions (P<0.05). Data
are shown as mean±s.d.

Fig. 2. Northern blot analysis of HS core protein and FGF receptor
expression. Total RNA blots of CMEC and HUVEC cultured under
hypoxic (+) or normoxic (–) conditions probed for expression of
syndecans 1,2 and 4, glypican-1, perlecan and FGF receptor 1 (FGF
R1). Ethidium bromide staining of the 18S RNA band is shown as
the loading control. Note the decreased expression of syndecan-1, 4
and glypican-1 under hypoxic conditions and the lack of significant
change in expression with other tested genes.
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Fig. 3. Effect of hypoxia and HIF1α gene expression on mRNA
levels of HS biosynthetic enzyme
expression. (A) RT-PCR analysis of
mRNA levels of enzymes involved
in GAG chain biosynthesis was
carried out on HUVEC (left panels)
and CEMC (right panel) cultured
under normoxic (C) or hypoxic
conditions for 6 hours (H6) or 24
hours (H24). In addition,
expression of the same enzymes
was measured in cells transduced
with an empty adenoviral vector
(C) or an adenoviral vector
carrying the HIF1α-VP16 construct
(HIF). The internal PCR loading
control with 18S ribosomal RNA is
show on the bottom of each panel.
(B,C) Quantitative analysis of GAG
chain biosynthesis enzymes
expression in HUVEC (B) and
CMEC (C) cells. The levels were
determined after cell culture under
normoxic conditions (gray bars),
after 6 hours (striped bars) or 24
hours (light striped bars) of
hypoxia or following infection with
a control (empty vector) adenovirus
(black bars) or a HIF1α-VP16
adenovirus (stippled bars).
Densitometric analysis of RT-PCRdetermined expression levels of
enzymes shown in (A) adjusted for
loading are shown as mean±s.d. of
three independent experiments.
Note the increased expression of
GlcNAcT-I, NDST1 and HS2ST in
both HUVEC and CMEC cultured
under hypoxic conditions or in
cells transduced with HIF1α-VP16
adenovirus. GlcNAcT-I, N-Acetyl
glucosamine transferase; NDST, Ndeacetyl/N-sulfotransferase;
HS2ST, heparan sulfate 2-O
sulfotransferase; CS/DS2ST,
chondroitin sulfate/dermatan
sulfate 2-O sulfotransferase;
HS6ST, heparan sulfate 6-O
sulfotransferase. * P<0.05 by
Student’s t-test.

0

CS/DS 2ST

HS6ST1

HS6ST2
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hypoxia, we performed northern analysis of FGF receptor 1
(FGFR1) expression. In both cell types, 24 hours of hypoxia
did not alter mRNA levels of FGFR1 (Fig. 2).

hybrid cDNA construct. An empty adenoviral vector was used
as control. In the cases of both HUVEC and CMEC,
transduction with an empty (control) adenoviral vector had no
significant effect on mRNA levels of any of the enzymes
assayed, as measured by densitometry of routine PCR (Fig. 3)
or by real time PCR.
Similar to findings in hypoxic cells, HIF-1α expression was
associated with increased expression of GlcNAcT-I, HS2ST,
NDST1 and NDST2 in both cell types (Fig. 3). Furthermore,
expression of HS6ST2, decreased by hypoxia in HUVEC but
not in CMEC, was similarly affected by adeno-HIF-1α
construct transduction (Fig. 3B,C). In the hypoxia studies, real
time PCR confirmed the magnitude of changes in enzyme
expression.

Effect of hypoxia on expression of enzymes involved in
HS and FGF2-HS chain synthesis
To determine whether the increase in the HS/CS ratio and in
the number of HS-FGF2 binding sites in hypoxic endothelial
cells is caused by an alteration in the expression of enzymes
involved in the biosynthesis of HS chains, we determined the
expression of various HS and CS biosynthesis enzymes in
HUVEC and CMEC cultured under normoxic conditions or
after 24 hours of hypoxia.
RT-PCR analysis demonstrated a significant increase in
the mRNA level of 1,4-N-acetylhexosaminyl transferase
(GlcNAcT-I), the enzyme responsible for initiation of HS chain
synthesis, N-sulfating enzymes NDST1 and NDST2, and
heparan sulfate 2-O sulfotransferase (HS2ST) in both cell types
under hypoxic conditions (Fig. 3A-C). To confirm these results,
we carried out quantitative real time PCR analysis of the
expression of these genes. In each case, real time PCR
confirmed the observed changes in expression, and the extent
of expression changes as determined by band densitometry
correlated well with real time PCR results. In particular,
HS2ST levels increased 3.9-fold in HUVEC at 6 hours, 4.6fold at 24 hours and 5.2-fold after transduction with HIF-1α,
whereas in CMEC, levels increased 2.2-fold at 6 hours, 3.3fold at 24 hours and 4.3-fold following HIF-1α transduction.
At the same time there were no significant change in
the expression of chondroitin/dermatan sulfate 2-O
sulfotransferase (CS/DS2ST) or C5 epimerase (Fig. 3A-C),
which was also confirmed by real time PCR analysis (data not
shown). In HUVEC, hypoxia also led to a somewhat decreased
expression of 6-O sulfotransferase isoforms HS6ST2
(0.63±0.34-fold, Fig. 4B, 0.75±0.1-fold by real time PCR),
whereas the expression of HS6ST1 was unchanged. The
expression of both 6-O sulfotransferase isoforms was
unchanged in CMEC (Fig. 3C).
Alterations in gene expression under hypoxic conditions are
frequently mediated by the HIF-1α transcription factor. To
examine whether HIF-1α is involved in modulation of HS
biosynthetic enzymes expression, we transduced HUVEC and
CMEC with an adenoviral vector carrying the HIF-1α–VP16

Hypoxia increases the ability of endothelial cells to
respond to bFGF-induced proliferation
The increased HS content of cell surface GAGs and an increase
in the number of low affinity (HS-FGF2) binding sites
following exposure to hypoxia suggest that the cells may
demonstrate altered sensitivity to FGF2 stimulation. To test this
possibility, the growth rate of both CMEC and HUVEC cells
in response to FGF2 was studied following 48 hours of culture
under normoxic or hypoxic conditions. The hypoxic cells
demonstrated significantly greater proliferative response to
FGF2 both in terms of cell number and 3H-thymidine uptake
(Fig. 4).
To evaluate whether this increased responsiveness was
caused by increased synthesis of 2-O-enriched HS on cellsurface-associated proteins or a general increase in the HS
mass, we added exogenous HS chains to CMEC and HUVEC
cells cultured under both normoxic and hypoxic conditions at
amounts calculated to double the total HS mass. The addition
of HS chains by themselves had little effect on cell
proliferation, and the extra HS did not enhance the ability of
FGF2 to stimulate cell growth under both sets of conditions
(Fig. 4).
Discussion
Hypoxia and ischemia trigger a multitude of responses
designed to compensate for reduced oxygen availability; these
responses include increased expression of angiogenic growth

Fig. 4. Effect of hypoxia on FGF2-induced
cell growth. Growth of CMEC and HUVEC
in 0.25% serum in the presence (+) or absence
(–) of FGF2 (10 ng/ml) was determined after
48 hours of hypoxia (+) or normoxia (–). For
each condition, the cells counts are
normalized to the baseline number taken as
100%. Note increased growth response to
FGF2 for both cell types cultured under
hypoxic conditions. *P<0.05 hypoxia versus
normoxia.
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factors, their receptors and specific integrins capable of
promoting these factors’ signaling (Semenza, 2000; Ware and
Simons, 1997). In this study we demonstrate that another set
of responses to hypoxia includes alterations in the cell-surfaceassociated HS matrix that results in increased endothelial cell
responsiveness to FGF2. In particular, we have shown that
hypoxic exposure of primary endothelial cells derived from
large veins or cardiac microvasculature results in a preferential
shift towards HS chains on the cell surface and an increase in
the number of FGF2-binding sites on HS chains.
Although both endothelial cell types demonstrated an
increase in the relative proportion of HS in the total cellsurface-associated GAG content (increased HS/CS ratio) and
an increased HS-FGF2 binding capacity, there were interesting
differences. Ischemic HUVEC had a much higher increase in
the HS content (per mg cell protein) than CMEC (1.6- versus
1.15-fold, respectively) and a higher increase in the HS/CS
ratio (2.6-fold versus 1.8-fold). However, the cell-surfaceassociated HS mass was nearly identical in both cell types
(21.1±0.2 versus 24.4±0.1 CPM per µg protein, respectively).
This shift towards HS chains under hypoxic conditions is
similar to results observed in bovine aortic and pulmonary
endothelial cells (Karlinsky et al., 1992).
Endothelial cell-surface-associated heparan sulfates are
carried on two major classes of core proteins - syndecans and
glypicans (Rosenberg et al., 1997; Tumova et al., 2000). The
four members of the Syndecan family of transmembrane
proteins are capable of carrying both HS and CS chains
(Bernfield et al., 1999; Zimmermann and David, 1999) and,
under normal conditions, less then 50% of these chains are HS
(Shworak et al., 1994). In contrast, glypican-1, the sole
member of the glypican family found in endothelial cells, is a
GPI-anchor-linked protein that carries essentially only HS
chains (Aviezer et al., 1994). Although both syndecans and
glypican can support FGF2-FGF receptor-1 interactions
(Rosenberg et al., 1997), syndecan-4 appears to be the principal
core protein involved in FGF2 signaling (Simons and
Horowitz, 2001; Volk et al., 1999).
In the absence of changes in syndecan and glypican
expression in both HUVEC and CMEC following 24 hours of
hypoxia, preferential synthesis of HS chains on syndecan cores
must account for the increase in the HS mass and the HS/CS
ratio. The observed increase in expression of GlcNAcT-I
(EXTL2) is in accord with this conclusion. EXTL2 is closely
related to the human EXT2 gene, a member of the hereditary
multiple exostoses (EXT) family of tumor suppressors, which
also encode HS polymerase of uncertain function (Lind et al.,
1998; McCormick et al., 1999). Although EXTL2 has been
purified on the basis of their ability to catalyze additions of
glucuronic acid and GlcNAc to the HS chain in vitro (Kitagawa
et al., 1999), to our knowledge this is the first demonstration
in an in vivo study of the effect of modulation of its expression
on the extent of HS chain synthesis.
In addition to the increase in the ratio of HS to CS, both cell
types demonstrated increased numbers of low affinity FGF2
binding sites per cell, which are thought to represent FGF2
binding by HS chains. Binding of FGF2 to heparan sulfate
chains requires the presence of iduronic acid 2 sulfate
(IdoA(2S)), with the affinity of oligosaccharides for FGF2
increasing with increasing number of IdoA(2S) residues
(Nugent and Iozzo, 2000; Rapraeger et al., 1994). The
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appearance of IdoA(2S) sites requires transformation of DGlcA into IdoA, which is carried out by GlcA C5 epimerase
followed by sulfation of IdoA in the 2-O position (Shworak
and Rosenberg, 1999), which in HS chains is carried out by the
enzyme HS2ST. The importance of HS2ST in formation of
FGF2-binding sites is confirmed by a marked reduction in
FGF2 binding in a mutant cell line lacking this enzyme (Bai
and Esko, 1996). In the current study, hypoxia was associated
with induction of expression of HS2ST in both HUVEC and
CMEC cells, whereas C5 epimerase levels remained
unchanged. Interestingly, there was no change in the
expression level of a related 2-O sulfotransferase involved in
formation of IdoA(2S) sites on CS and DS chains (CS/DS2ST).
In addition to 2-O sulfation, 6-O sulfation, which is carried
out by 6-O sulfotransferase, and, in particular, the presence of
IdoA(2S)alpha1,4GlcNSO3(6S) disaccharide also appear to be
important for FGF2 signaling (Pye et al., 1998) since 6-O
sulfates are involved in hydrogen bonding between the HS
chain and the FGF receptor (Schlessinger et al., 2000). The
relative specificities of the two known 6-O HS sulfotransferase
isoforms (HS6ST-1 and HS6ST-2) have not been established.
Neither isoforms’ expression was altered by hypoxia in
microvascular endothelial cells whereas only HS6ST2 was
decreased by hypoxia in HUVEC.
We have also observed the increase in expression of both
NDST1 and NDST2 genes.
The N-sulfation of HS chains, carried out by NDST
enzymes, plays an important role in development. Of the four
NDST isoforms, only NDST1 and 2 show a widespread pattern
of expression (Aikawa and Esko, 1999). Disruption of the
NDST2 gene results in a severe mast cell defect while not
significantly affecting HS composition in other organs
(Forsberg et al., 1999). On the other hand, disruption of the
NDST1 gene causes structural alterations in HS in most
basement membranes, leading to neonatal mortality (Ringvall
et al., 2000). Although little is known regarding the
physiological consequences of increased expression of these
enzymes, increased NDST-1 activity results, in addition to
increased N-sulfation, in increased chain length (Pikas et al.,
2000). This increase in the HS chain length may result in an
increased number of FGF2-binding sites per HS chain even in
the absence of increased 2-O sulfation activity.
Hypoxia induces a variety of cellular responses, ranging
from upregulation of VEGF and VEGF receptor 1 to increased
expression of glucose transporters (Semenza, 2000). Most of
these are thought to be mediated by the transcription factor
HIF-1α (Carmeliet et al., 1998; Semenza, 2000) although its
recently described analog, HIF-2α, may also be involved
(Blancher et al., 2000). To investigate the potential role of HIF1α in hypoxia-mediated induction of GAG biosynthetic
enzymes, we analyzed their expression in HUVEC and CMEC
transduced with an adenovirus carrying a HIF-1α cDNA
construct with a deleted oxygen-dependent degradation
domain fused with a VP16 activation domain (Vincent et al.,
2000). The native form of HIF-1α is inherently unstable under
normal conditions owing to the presence of the oxygendependent degradation domain, which facilitates ubiquitination
and the subsequent degradation of the protein. The removal of
this domain or selective mutations within it result in
stabilization of the HIF-1α protein (Huang et al., 1998; Sutter
et al., 2000).
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The adenovirus-mediated expression of the HIF1α-VP16
fusion construct in both HUVEC and CMEC produced a GAG
enzyme expression pattern that closely mimicked findings in
the hypoxic cells. This was equally applicable to enzymes that
were upregulated (GlcNAcT1, HS2ST, NDST1 and NDST2),
downregulated (HS6ST2- in HUVEC only) or unchanged
(HS6ST1, CS/DS2ST and epimerase) by hypoxia. We
conclude, therefore, that the expression of these genes is most
probably controlled by HIF-1α.
The alteration in the HS cell surface composition, which is
more pronounced in HUVEC than CMEC, had a profound
impact on cell responsiveness to FGF2 in a proliferation assay;
both cell types demonstrated faster growth rate in the presence
of FGF2 under hypoxic conditions. The magnitude of this
increase in FGF2 responsiveness closely paralleled the
magnitude in increased HS mass. In keeping with the larger
increase in the number of low affinity FGF2 binding sites
on HUVEC than CMEC, the former demonstrated a more
pronounced increase in the FGF2-induced growth rate than the
latter. This increased FGF2 responsiveness could not be
attributed to changes in the FGF receptor levels or changes in
the affinity (FGF R1) as both of these parameters were largely
unchanged.
Furthermore, it is unlikely that a simple increase in HS chains
(rather then an alteration in HS surface composition) is
responsible for this effect, since the addition of HS chains by
themselves did not stimulate cell proliferation, and the extra HS
had little effect on the ability of FGF2 to stimulate cell growth
under normoxic or hypoxic conditions. Rather, we hypothesize
that the increase in cell-associated HS chains enriched in 2-O
sulfates is responsible for this effect. In support of this thesis is
an observation of hypoxia-induced increase in the total cellassociated HS mass and in HS2ST levels (and, by implication,
an increase in the 2-O fraction of the total HS mass).
It is likely that the cell-surface-associated HS and not the
extracellular HS is responsible for enhanced FGF2 signaling.
As already noted, the addition of HS to the cell culture medium
under either normoxic or hypoxic conditions had no effect on
response to FGF2 in either HUVEC or CMEC cells. Although
this HS was not selectively enriched in the 2-O sulfated
fraction, the overall amount of 2-O HS was doubled,
mimicking overall changes in HS composition observed in
hypoxic HUVEC cells. The difference from the latter situation,
however, is that this additional total HS (and its 2-O HS
fraction) is not on cell-membrane-associated core proteins. Of
these, syndecan-4 is likely to be particularly important with
regard to FGF2 signaling, since its overexpression but not that
of glypican-1 or syndecan-1 enhances FGF2 signaling (Simons
and Horowitz, 2001).
In summary, hypoxia induces alterations in HS composition
on the endothelial cell surface that enhances cell
responsiveness to FGF2. This effect is mediated by an increase
in total cell surface HS chains as well as by an increase in the
number of HS-FGF2 binding sites. Both of these changes are
mediated by a HIF-1α-dependent increase in expression of
enzymes responsible for preferential HS versus CS chain
synthesis (GlcNAcT-I) and generation of FGF2 binding sites
(HS2ST). This novel mechanism may constitute an important
adaptive response to hypoxia and may play a fundamental role
in control of angiogenesis by regulating cellular interactions of
heparin-binding growth factors.
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